Dudediligence.

Monopar Therapeutics Inc

MNPRNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Aug 128-KResults of operations2.029.01
  2. Aug 1210-QQuarterly report
  3. Jul 228-KRegulation FD disclosure7.019.01
  4. Jun 308-KRegulation FD disclosure7.019.01
  5. Jun 268-KRegulation FD disclosure7.019.01
  6. Jun 238-KShareholder vote5.07
  7. May 298-KRegulation FD disclosure7.019.01
  8. May 198-KRegulation FD disclosure7.019.01
  9. May 1410-QQuarterly report
  10. May 148-KResults of operations2.029.01
  11. Apr 208-KRegulation FD disclosure7.019.01
  12. Mar 278-KResults of operations2.029.01
  13. Mar 2710-KAnnual report
  14. Mar 28-KRegulation FD disclosure7.019.01
  15. Nov 13, 20258-KResults of operations2.029.01
  16. Nov 13, 202510-QQuarterly report
  17. Nov 10, 20258-KRegulation FD disclosure7.019.01
  18. Sep 24, 20258-KMaterial agreement and Regulation FD disclosure1.017.019.01
  19. Sep 24, 2025424B5Prospectus for an offering
  20. Sep 15, 20258-KRegulation FD disclosure7.019.01
  21. Aug 29, 2025S-3Shelf registration
  22. Aug 12, 20258-KResults of operations2.029.01
  23. Aug 12, 202510-QQuarterly report
  24. Jun 20, 20258-KShareholder vote5.07
  25. May 13, 202510-QQuarterly report
  26. May 13, 20258-KResults of operations2.029.01
  27. May 7, 20258-KRegulation FD disclosure7.019.01
  28. Mar 31, 20258-KResults of operations2.029.01
  29. Mar 31, 202510-KAnnual report
  30. Mar 3, 20258-KOfficer or director change5.029.01
  31. Feb 24, 20258-KOfficer or director change5.029.01
  32. Jan 27, 2025424B3Prospectus for an offering
  33. Jan 15, 2025S-3Shelf registration
  34. Dec 23, 20248-KMaterial agreement and unregistered sale of shares1.013.029.01
  35. Dec 23, 2024424B5Prospectus for an offering
  36. Dec 18, 2024424B3Prospectus for an offering
  37. Dec 6, 20248-KRegulation FD disclosure7.019.01
  38. Nov 29, 2024S-3Shelf registration
  39. Nov 8, 20248-KResults of operations2.029.01
  40. Nov 8, 202410-QQuarterly report
  41. Oct 30, 20248-KMaterial agreement and Regulation FD disclosure1.017.019.01
  42. Oct 29, 2024424B5Prospectus for an offering
  43. Oct 28, 2024424B5Prospectus for an offering
  44. Oct 24, 20248-KMaterial agreement and acquisition or sale of assets completed1.012.012.033.027.018.019.01
  45. Oct 22, 20248-KRegulation FD disclosure7.019.01